Ancrod-specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same
US6365155B1 · kind B1 · utility
0Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 30, 1999 |
| Grant date | Apr 2, 2002 |
| Priority date | — |
| Expiry date | Dec 30, 2019 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/96433
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Ancrod-specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof are used in pharmaceutical preparations and in diagnosis. Cells which express these antibodies, antibody fragments, mixtures or derivatives thereof are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.